---
title: Fractionated stereotactic radiotherapy of brainstem metastases - Clinical outcome
  and prognostic factors
date: '2024-12-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39651456/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241209184155&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: FSRT for BSM is as an effective and safe treatment approach
  with high LC rates and reasonable neurological toxicity despite the poor prognosis
  in this patient cohort is still very poor. Clinical and imaging follow-up is necessary
  to identify cerebral progression and adverse toxicity including ...'
disable_comments: true
---
CONCLUSION: FSRT for BSM is as an effective and safe treatment approach with high LC rates and reasonable neurological toxicity despite the poor prognosis in this patient cohort is still very poor. Clinical and imaging follow-up is necessary to identify cerebral progression and adverse toxicity including ...